PolyPeptide outlines next dates in Samsung Biologics tender offer
EQS reported that PolyPeptide disclosed the tender offer’s provisional result, with the definitive result and a possible extra acceptance period due in October.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
According to eqs-news.com, PolyPeptide Group AG said a Samsung Biologics subsidiary had published a provisional interim result for its tender offer. The definitive interim result is expected on October 16, 2026.
If the outcome is successful, holders would have an additional 10-day acceptance period from October 19 through October 30. The period remains subject to customary conditions and approvals at an extraordinary general meeting. The meeting, scheduled for October 26, will consider key amendments including the removal of transfer and voting restrictions, as well as changes to the board of directors.
why it matters
The update sets the next key dates for the takeover process: the definitive interim result on October 16, a possible additional acceptance window, and the October 26 meeting. Regulatory approvals and other customary conditions remain outstanding.
instruments
sources
- PolyPeptide Group AG (8H0) Updates on Tender Offer Timeline — eqs-news.com, 13 October 2026 at 05:10 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗